AAO 2018 Speakers

Olav Hellebø joined ReNeroun group in the UK as CEO in 2014. Previously he was CEO of the oncology biotech Clavis Pharma in Oslo, Norway.…

Rich Small joined Neurotech in 2007 and has been Neurotech’s CEO since December 2017. Rich previously served as the Company’s COO and CFO. He has…

Clark E. Tedford, Ph.D. is one of the founders of LumiThera and has served as President and CEO since 2013. Previously Dr. Tedford was Vice…

James McLaughlin is president, CEO and co-founder of Gemini Therapeutics, and has led the company since its inception in 2015. James has a background in…

Dr. Hoffman has been Chief Executive Officer of Aerpio Pharmaceuticals since December 2017. Prior to Aerpio, Dr. Hoffman was a Senior Advisor to PDL BioPharma,…

Miki Kapoor is CEO of Verana Health. With two decades of diverse experience in healthcare, in operations, finance, strategy and policy, Miki has a notably…

Dr. Franziska Ullrich pursued her B.Sc. and M.Sc. in mechanical engineering and robotics at ETH Zurich in Switzerland and gained complementary experience during practical work…

Jill leads Ophthalmology in Personalized Health Care at Roche-Genentech. She oversees and coordinates all efforts in the development of meaningful data at scale and advanced…

Omar R. Sadruddin, MD currently serves as Santen’s Global Medical Director for the Surgical Glaucoma business. Dr. Sadruddin brings a deep knowledge of ophthalmic devices…

Anthony B. Daniels, M.D., M.Sc., is Assistant Professor of Ophthalmology and Visual Sciences and the Director of Ocular Oncology at the Vanderbilt Eye Institute and…

Dr. Antonetti received his PhD in Cellular and Molecular Biology at The Penn State College of Medicine under the direction of Dr. Leonard Jim Jefferson…